Loading chart…
PRE-MARKET
Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments.
Vivimed Labs Limited (VIVIMEDLAB) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The VIVIMEDLAB share price is ₹5.40 (-0.18% today), with a market capitalisation of ₹45Cr. MarketRipple tracks the VIVIMEDLAB investment thesis, the ripple-chain impact of market events on Vivimed Labs Limited, and the Healthcare sector outlook.
Open
₹5.40
High
₹5.50
Low
₹5.31
Prev. Close
₹5.41
52W High
₹29.40
52W Low
₹4.75
Day range
₹5.31–₹5.50
52-week range
₹4.75–₹29.40
Volume
11K
P/E
—
ROE
83.8%
D/E
-1.89
Margin
-231.3%
Vivimed Labs Limited (NSE: VIVIMEDLAB) is currently trading at ₹5.40 (-0.18%).
Vivimed Labs Limited's market capitalization is ₹45Cr.
Vivimed Labs Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).